Intravitreal cidofovir for the maintenance treatment of cytomegalovirus retinitis (Q46792666)

25 December 2017

title

Intravitreal cidofovir for the maintenance treatment of cytomegalovirus retinitis (English)

1 reference

25 December 2017

0 references

F M Rahhal

1

1 reference

25 December 2017

J F Arevalo

2

1 reference

25 December 2017

D Munguia

3

1 reference

25 December 2017

I Taskintuna

4

1 reference

25 December 2017

E Chavez de la Paz

5

1 reference

25 December 2017

S P Azen

6

1 reference

25 December 2017

W R Freeman

7

1 reference

25 December 2017

publication date

1 July 1996

1 reference

25 December 2017

published in

Ophthalmology

1 reference

25 December 2017

volume

103

1 reference

25 December 2017

issue

7

1 reference

25 December 2017

page(s)

1078-1083

1 reference

25 December 2017

Clinical manifestations of AIDS in the era of pneumocystis prophylaxis. Multicenter AIDS Cohort Study

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2896%2930564-2

7 January 2021

Mortality in patients with the acquired immunodeficiency syndrome treated with either foscarnet or ganciclovir for cytomegalovirus retinitis

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2896%2930564-2

7 January 2021

A Randomized, Controlled Trial of Foscarnet in the Treatment of Cytomegalovirus Retinitis in Patients with AIDS

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2896%2930564-2

7 January 2021

Pathophysiology and treatment of clinically resistant cytomegalovirus retinitis

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2896%2930564-2

7 January 2021

Combination ganciclovir and foscarnet in the treatment of clinically resistant cytomegalovirus retinitis in patients with acquired immunodeficiency syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2896%2930564-2

7 January 2021

Treatment of serious cytomegalovirus infections with 9-(1,3-dihydroxy-2-propoxymethyl)guanine in patients with AIDS and other immunodeficiencies

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2896%2930564-2

7 January 2021

Long-term intravitreal ganciclovir therapy for cytomegalovirus retinopathy

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2896%2930564-2

7 January 2021

Efficacy and tolerance of intravitreal ganciclovir in cytomegalovirus retinitis in acquired immune deficiency syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2896%2930564-2

7 January 2021

Treatment of cytomegalovirus retinitis with an intraocular sustained-release ganciclovir implant. A randomized controlled clinical trial.

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2896%2930564-2

7 January 2021

Sustained-release ganciclovir therapy for treatment of cytomegalovirus retinitis. Use of an intravitreal device

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2896%2930564-2

7 January 2021

Control of cytomegalovirus retinitis using sustained release of intraocular ganciclovir

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2896%2930564-2

7 January 2021

A novel selective broad-spectrum anti-DNA virus agent

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2896%2930564-2

7 January 2021

Selective inhibition of human cytomegalovirus DNA synthesis by (S)-1-(3-hydroxy-2-phosphonylmethoxypropyl)cytosine [(S)-HPMPC] and 9-(1,3-dihydroxy-2-propoxymethyl)guanine (DHPG).

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2896%2930564-2

7 January 2021

(S)-1-(3-hydroxy-2-phosphonylmethoxypropyl)cytosine, a potent and selective inhibitor of human cytomegalovirus replication

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2896%2930564-2

7 January 2021

Phase I/II study of intravitreal cidofovir for the treatment of cytomegalovirus retinitis in patients with the acquired immunodeficiency syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2896%2930564-2

7 January 2021

Intravitreal cidofovir (HPMPC) treatment of cytomegalovirus retinitis in patients with acquired immune deficiency syndrome.

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2896%2930564-2

7 January 2021

Cytomegalovirus retinitis and acquired immunodeficiency syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2896%2930564-2

7 January 2021

Surgical Repair of Rhegmatogenous Retinal Detachment in Immunosuppressed Patients with Clytomegalovirus Retinitis

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2896%2930564-2

7 January 2021

Risk factors for development of rhegmatogenous retinal detachment in patients with cytomegalovirus retinitis.

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2896%2930564-2

7 January 2021

10.1016/S0161-6420(96)30564-2

Identifiers

DOI

1 reference

25 December 2017

1 reference

25 December 2017